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1. Introduction 
The autogenous arteriovenous fistula (AVF) is the preferred access for chronic hemodialysis 
in patients with end-stage kidney disease. Careful examination of the upper extremity is 
essential for the creation of a successful fistula. The quality of the arterial and venous 
circulation should be well established prior to surgery. However, there are cases when the 
superficial venous system of the upper extremity is unsuitable for the creation of an 
autogenous AVF. This problem has two solutions: the use of a prosthetic graft or the 
creation of a brachio-brachial AVF. Prosthetic grafts have a 1-year patency rate of 65-
75%(Haimov, 1978), mostly due to the frequent and varying complications that they may 
sustain, especially ischemia, thrombosis, infection, and aneurysms. The brachio-brachial 
AVF, a relatively new type of angioaccess, is shown to have similar patency rates to the 
prosthetic grafts, but without their number of complications and is a very good alternative 
for patients with an unsatisfactory superficial venous system (Dorobanţu et al., 2006, 2010). 
2. Anatomy of the brachial artery and the venous system of the upper arm 
The brachial artery is the continuation of the axillary artery beyond the inferior margin of 
the teres major muscle. It continues down the anterior aspect of the arm to the cubital fossa, 
being accompanied by two venae comitantes and the brachial nerve. Proximally, the nerve is 
lateral to the artery but it crosses the medial side of the artery distally, lying anterior to the 
elbow joint. The brachial artery divides into its terminal branches, the radial and the ulnar, 2 
cm below the elbow bend (Gabella, 1995). 
The venous system of the upper extremity comprises the superficial and the deep veins. 
Both groups have valves. The superficial veins (figure 1) are the the cephalic, the basilic and 
the median vein of the forearm; they are subcutaneous in the superficial fascia. The cephalic 
vein forms over the “anatomical snuffbox” and ascends along the forearm’s radial side and 
then in front of the elbow, in a groove between the brachioradialis and the biceps. It then 
crosses anteriorly the lateral cutaneous nerve and continues along the lateral border of the 
biceps, up to the delto-pectoral groove. It pierces the clavipectoral fascia and joins the 
axillary vein below the clavicular level. 
The basilic vein begins medially in the hand’s dorsal venous network and continues on the 
medial side of the forearm and then anterior to the elbow. Just distally to the elbow, it is 
joined by the median vein of the forearm. It ascends superficially between the biceps and the 
pronator teres, between filaments of the medial cutaneous nerve. It perforates the deep 
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fascia midway in the arm, continuing medial to the brachial artery to the lower border of the 
teres major, where it becomes the axillary vein. 
 
 
Fig. 1. The superficial veins of the upper limb 
 
 
Fig. 2. The deep veins of the upper limb 
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The brachial veins (figure 2) share their path with the brachial artery. They begin at the 
junction between the radial and the ulnar veins and end at the inferior margin of the teres 
major muscle, where they are joined by the basilic vein, forming the axillary vein. There are 
many collaterals between the two veins and small tributaries that drain the muscles of the 
upper arm (Lupu et al., 2010). 
3. Hemodynamics of an arteriovenous fistula 
The arteriovenous fistula is an abnormal connection between a donor artery and a receiving 
vein. The permeability of the fistula depends on several factors. One of them is the 
resistance of the outflow vascular bed, which in this case is venous, and thus has a low 
pressure and a low resistance. As the vein’s diameter increases through the maturation 
process, the venous resistance decreases. This process occurs during the first 4-8 weeks after 
the creation of the AVF and comprises a thickening of the venous wall, an increase in 
diameter for the vein, its distal branches, and for the arterial segment proximal to the 
anastomosis. As the vein is connected to a high-pressure, high-velocity artery, the blood 
flow through the vein induces an increased wall shear stress. Experiments have shown that 
acute increases in wall shear stress results in endothelial release of nitric oxide, which in 
turn increases the lumen radius. This is available for both acute and chronic wall shear 
alterations (Zarins et al., 2004). Experimentally produced arteriovenous fistulas produce an 
immediate 10-fold increase in blood flow and a three-fold increase in wall shear stress. 
Within 24 hours, vessel enlargement begins, and at the end of 4 weeks lumen radius 
enlarges twofold and wall shear stress returns to normal (Masuda & Bassiouny, 1989). 
The flow through the AVF is insignificant as long as the vein’s diameter doesn’t exceed that 
of the artery by at least 20%; however, a palpable thrill means that the AVF is functional. 
When the diameter of the vein exceeds that of the artery by 75%, the venous resistance is 
virtually null, and the flow through the fistula is limited only by the arterial flow. Between 
20 and 75%, the flow through the AVF increases on an exponential basis and it depends 
mainly on the venous resistance (Hobson et al., 1973). 
It is noteworthy that the portion of the artery distal to the AVF does not suffer any 
modifications, thereby maintaining its high resistance relative to the outflow of the fistula. 
This can lead to a reversal of flow in this segment, the so-called “steal syndrome”, which can 
result in ischemic complications. This is especially true in proximal fistulas. 
The body’s adaptation to the presence of an AVF includes global decreased vascular 
resistance and an increase in cardiac output, which can lead to a hyperdynamic syndrome or 
even to congestive heart failure. This is easily explained when the flow through a fistula 
ranges from 650 ml/min (for a radio-cephalic fistula) to 1000-1100 ml/min (for a brachio-
cephalic, brachio-brachial or prosthetic fistula) (Schanzer, 2004; Ştiru, 2006). Any 
cardiovascular comorbidity can alter these patients’ long-term prognosis. 
4. Advantages of an autogenous arteriovenous fistula 
A great number of studies have proven higher patency rates and lower complication rates 
for autogenous AVF when compared to synthetic bridge AVF (Palder et al., 1985; Enzler et 
al., 1996; Matsuura et al., 1998; Kherlakian et al., 2006; Kappos et al., 2007). Taking this into 
account, the National Kidney Foundation Dialysis Outcomes Quality Initiative (NKF-DOQI) 
guidelines for vascular access emphasize the use of the former over the latter (NKF-DOQI, 
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2001). Prosthetic and autologous AVF have similar patency rates for the first 4 postoperative 
weeks. After this period of time, synthetic bridge grafts require further interventions for 
angioplasty. Even with newer types of grafts, such as the Vectra Vascular Access grafts, the 
primary assisted rate of the prosthetic AVF is lower that of the autogenous AVF at 18 
months of follow-up (58% vs 78%, respectively) (Kappos, 2007). The same study shows an 
overall access thrombosis rate of 17% for autogenous AVF and 34% for the Vectra graft. This 
rate is higher for other materials, such as ePTFE (Segal et al., 2003; Choi et al., 2003). 
Most complications can be treated conservatively, without compromising the fistula 
(Matsuura et al., 1998). Severe hand ischemia, necessitating surgical treatment, occurs in 1% 
of patients with AVF and 2.7-4.3% of patients with graft AVF (Porter et al., 1985). Also, steal 
syndrome occurs in 73% of autogenous AVF and in 91% of graft AVF, as demonstrated by 
hemodynamic studies. Therapeutic options for hand ischemia always involve surgical 
interventions and include banding of the AVF (which is sometimes impractical, especially 
with prosthetic AVFs) and complex revascularization procedures. 
Infection is a rare complication of the autogenous AVF; because there is no foreign body, it 
responds well to drainage and antibiotics. On the other hand, an infected prosthetic graft is 
a potentially lethal complication. The presence of foreign material makes this complication 
very difficult to treat. Prophylactic antibiotics are given before constructing the prosthetic 
AVF. Treatment requires removal of the whole prosthetic segment, debridement and 
systemic antibiotics.  
Perigraft seroma is a very rare complication of the autogenous AVF  (Blumenberg et al., 
1985). It is more common with prosthetic grafts, because of changes in the structure of the 
ePTFE and of certain biological alterations in the host (Sladen & Mandl, 1985; Ahn & 
Machleder, 1986). Minimally invasive treatment is often unsuccesful, so more aggressive 
measures must be taken, leading even to replacement of the graft.  
There is also a decreased risk of intimal hyperplasia because the anastomosis is much smaller 
compared to the one used with a prosthetic graft (Lumsden & Chen, 1997). In the rare case of 
fistula failure, the surgeon still has the backup possibility of creating a synthetic bridge fistula, 
an option that he would lose should he employ a prosthetic fistula in the first place. 
5. Surgical technique 
We use the two-stage approach in creating a functional brachio-brachial fistula. Although a 
single-stage approach has been described by Bazan and Schanzer (Bazan & Schanzer, 2004), 
we found the two-stage procedure to be safer as mobilization of the arterialized vein is 
easier than the thin-walled initial vein (Dorobanţu et al., 2010). 
The first stage involves anastomosing the brachial vein to the brachial artery. The upper 
extremity is circumferentially prepared up to the axilla and is placed in extension and 
abduction, with the hand in supination. Local anesthesia is used, infiltrating 1% Lidocaine in 
the cutaneous and subcutaneous tissue. A 4-5 cm longitudinal  incision is made in the 
antecubital fossa, following the medial border of the biceps muscle. The muscle is retracted 
slightly laterally in order to allow access to the thin aponeurotic sheath which contains the 
neuro-vascular bundle. The sheath is opened and the artery is dissected clear of the median 
nerve, passing a loop tape underneath it. With the arteries are two venae comitantes, 
connected by fragile transverse and oblique branches. The vein with the greater diameter is 
chosen for the AVF. All of its branches are ligated and a longitudinal venotomy is 
performed. Flushing the vein with a heparinated saline solution (2500 units in 250 ml of 
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saline) verifies the vein’s permeability. The entire length of the catheter is inserted into the 
vein. Now the brachial artery is cross-clamped proximally and distally to the proposed site 
of anastomosis and a longitudinal arteriotomy is performed. An end-to-side anastomosis is 
performed using a running nonabsorbable 7-0 polypropilene suture. The posterior wall is 
performed first and the brachial vein is divided distally before completing the anastomosis.  
Before tying the suture, the permeability of the fistula, as well as of the brachial artery 
should be evaluated. The vein should be inspected for a thrill; its absence indicates poor 
outflow and the surgeon must look for a potential problem and correct it (figure 3). All 
bleeding sources should be controlled and the skin is closed using interrupted simple 
sutures, without drainage (Ştiru, 2006; Iliescu, 2007). 
 
 
Fig. 3. The brachio-brachial fistula – intraoperative view 
After 4 weeks, the vein is evaluated using Duplex scanning and, if its diameter is greater than 
4 mm, it is transposed in a superficial plane in order to ease access for punctures. A 
longitudinal incision is performed on the antero-medial side of the arm, from the antecubital 
fossa to the axillary region. The neuro-vascular bundle is exposed, with the vein on the lateral 
side, the artery in the middle and the median nerve on the medial side. All of the venous 
collaterals are ligated, thus mobilizing the vein so that the aponeurosis can be closed 
underneath the vein with interrupted sutures (figure 4). A drainage tube is inserted and kept 
in place for 24 hours. The skin is closed with interrupted sutures, making sure that there is a 
1.5 cm layer of tissue between the vein and the skin’s surface to allow healing between needle 
punctures. The fistula can be used for hemodialysis after 3 weeks (Schanzer, 2004; Ştiru, 2006). 
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Fig. 4. Mobilization of the brachial vein 
6. Results 
Between 2004 and 2007 our team has operated on 49 patients with an upper arm venous 
system unsuitable for long term hemodialysis access, creating 49 brachio-brachial fistulas 
(Dorobantu et al., 2010). To date, this is the largest reported cohort of patients with a 
brachio-brachial AVF. Other groups have reported 17 (Casey et al., 2008), 20 (Angle et al., 
2005) and 21 patients (Elwakeel et al. 2007). Thirty-nine patients (79,6%) had a functional 
fistula at the time of brachial vein transposition, after 4 weeks. The follow-up study was 
performed only in patients with a native functional brachio-brachial fistula after the two-
step procedure. Mean follow-up period was 18.0 ± 11.1 months (range 3-37 months), longer 
than that of other published works, which ranged from 8 to 15.85 months. The overall 
patency rate at 37 months was 82.1%, compared to 75.89% at 1 year and 55.39% at 2 years 
reported by Elwakeel and 40% at 1 year reported by Casey. During this period, only seven 
patients presented with fistula occlusion 6, 6.4, 7.1, 9.4, 12.3, 23.5 and 35.0 months, 
respectively after superficialization.  
No major complications have occurred with the patients. In 17 cases (43.6%) we noted 
discrete edema of the forearm, which disappeared after the first post-operative month; in 
only two cases has the edema extended to the entire arm. This  was probably related to the 
greater pressure at the level of the remaining brachial vein, due to arterial pressure at the 
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level of the brachio-brachial fistula, and numerous collaterals between the two brachial 
veins. In nearly all the patients we noted the presence of a collateral superficial venous 
network, as an adaptive reaction to the greater pressure in the deep venous system. After 
the superficialization and the ligation of the collaterals between the two brachial veins, this 
edema disappeared. We noted only one important edema of the arm, which regressed after 
the transposition in the subcutaneous tissue of the arterialized brachial vein. We believe that 
the absence of other complications like persistent forearm edema, ischemic lesions, etc, was 
related to the presence of two satellite brachial veins; therefore, the remaining brachial vein 
sustains the deep venous drainage. Other groups have reported a higher number of 
complications, including hematomas, wound infections (Casey, 2008) and steal syndrome 
which required reintervention and revascularization of the upper extremity. 
 
 Casey Angle Elwakeel Dorobanţu 
No. of patients 17 20 21 49 
Mean follow-
up (months) 
8 14 ± 4 15.85 ± 9 18 ± 11.1 
Maturation 
rate at 4 weeks 
47% 100% 66.6% 79.6% 
Patency rate  
At 12 months 40% 75.89%  
At 24 months 55.39%  
At 37 months 82.1% 
Major 
complications 
    
 Hematoma
 Infection 
 Steal sdr. 
 Aneurysm 
 2 
 2 
 3 
 0
 
 1 
 1 
 0 
 2
0 
Table 1. Comparison between several groups of patients with brachio-brachial fistulas 
There were two cases of technical difficulties in mobilization of the brachial vein that had 
not been reported before: in one case we managed to maintain the native AVF (due to 
successful reconstruction of the arterialized vein in front of the median nerve) (figures 5 & 
6), while in the other case where the arterialized vein remained too small, we were forced to 
make a prosthetic fistula. That was a rare event and we believe that it does not diminish the 
good results achieved with this technique. 
No operative deaths occurred, but three patients died (after 2, 8 and 10 months) due to non-
related causes and another three patients were lost at follow-up. 
We consider that pre-operative ultrasound deep vein evaluation for the first step of the 
procedure is useless because the brachial vein is always a good native conduit with a 
variable diameter which does not influence the future of the AVF. Although there are 
authors that used only brachial veins with a diameter superior to 3 mm, they did not resolve 
the non-maturation problem (Pisoni et al., 2002). 
When compared to the more traditional brachio-cephalic and brachio-basilic AVF, the 
brachio-brachial fistula shows similar patency and complications rates. A study published 
by Woo et al. in 2007, analyzing 190 patients with brachio-cephalic and brachio-basilic AVFs 
shows a patency rate of 56% for the brachio-cephalic and 71% for the brachio-basilic at 1 
year. At 5 years, the patency rate was 40% for the brachio-cephalic and 56% for the brachio-
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basilic. Complications rates were low, including 6 cases of steal syndrome (3.15%), 7 cases of 
bleeding (3.68%), 3 cases of infection (1.57%) and 1 case of early thrombosis (0.52%), but 
greater than in the brachio-brachial AVF. 
 
 
Fig. 5. The arterialized brachial vein runs under the median nerve 
 
 
Fig. 6. Final result, after the vein has been divided and reconnected using an end-to-end 
anastomosis 
7. Conclusions 
The brachio-brachial arteriovenous fistula is a viable solution for patients with an unsuitable 
superficial venous system. It can also be used in patients who already have malfunctioning 
arteriovenous fistulas using the superficial veins of the upper extremity. Studies have 
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shown that it has good patency and low complication rates, therefore its construction can 
postpone the use of a prosthetic bridge graft or a long-life hemodialysis catheter by several 
years. The surgical technique includes the same principles of other venous transpositions, so 
it should be incorporated into the arsenal of techniques that are routinely used by vascular 
access surgeons. 
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